First Header Logo Second Header Logo

Lance Miller

Concepts (479)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
39
2018
765
3.790
Why?
Gene Expression Profiling
37
2020
322
2.740
Why?
Gene Expression Regulation, Neoplastic
31
2018
261
2.340
Why?
Oligonucleotide Array Sequence Analysis
23
2016
160
1.310
Why?
Appendiceal Neoplasms
3
2020
98
1.280
Why?
Neoplasms
6
2020
726
1.110
Why?
Prognosis
25
2020
1495
1.090
Why?
Immunotherapy
6
2020
81
0.990
Why?
Peritoneal Neoplasms
3
2020
259
0.850
Why?
Humans
87
2020
31974
0.800
Why?
Evolution, Molecular
2
2016
34
0.800
Why?
Lung Neoplasms
6
2019
412
0.740
Why?
Female
56
2020
19939
0.710
Why?
CD8-Positive T-Lymphocytes
1
2020
91
0.660
Why?
Iron
5
2017
116
0.640
Why?
Cell Line, Tumor
29
2018
726
0.640
Why?
Receptors, Estrogen
12
2018
113
0.640
Why?
Cell Proliferation
13
2018
604
0.620
Why?
Cluster Analysis
10
2016
125
0.590
Why?
Immunity
2
2016
22
0.570
Why?
Brain Neoplasms
6
2019
638
0.570
Why?
Carcinoma, Non-Small-Cell Lung
3
2019
101
0.550
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2020
458
0.540
Why?
Cancer Vaccines
1
2015
24
0.520
Why?
Computational Biology
8
2020
91
0.510
Why?
Genomics
5
2018
85
0.490
Why?
Mice
17
2020
2484
0.460
Why?
Tumor Suppressor Protein p53
4
2017
82
0.460
Why?
Oncogenes
3
2020
13
0.450
Why?
Genes, Immunoglobulin
1
2013
4
0.450
Why?
Major Histocompatibility Complex
1
2013
16
0.440
Why?
Mutation
5
2017
489
0.440
Why?
Animals
24
2020
7541
0.410
Why?
Transcription, Genetic
8
2010
137
0.400
Why?
Algorithms
8
2015
492
0.400
Why?
Transcription Factors
5
2013
181
0.390
Why?
Neoplasm Staging
7
2018
447
0.380
Why?
Middle Aged
22
2020
11804
0.370
Why?
Tamoxifen
7
2015
59
0.360
Why?
Glioblastoma
3
2018
156
0.360
Why?
Genes, ras
1
2009
26
0.340
Why?
YY1 Transcription Factor
3
2016
6
0.340
Why?
Adaptor Proteins, Signal Transducing
1
2009
67
0.330
Why?
Carcinoma, Hepatocellular
3
2019
60
0.330
Why?
Proportional Hazards Models
4
2020
753
0.320
Why?
Membrane Proteins
2
2009
256
0.320
Why?
Melanoma
3
2019
164
0.320
Why?
Adenocarcinoma
5
2019
308
0.320
Why?
Adult
15
2020
9339
0.310
Why?
Gene Expression Regulation
5
2016
495
0.310
Why?
Liver Neoplasms
3
2019
155
0.300
Why?
Mice, Inbred BALB C
4
2020
167
0.300
Why?
SARS Virus
2
2004
7
0.300
Why?
Survival Rate
6
2020
877
0.290
Why?
Estrogen Receptor alpha
4
2016
52
0.290
Why?
DNA, Bacterial
1
2007
27
0.290
Why?
Treatment Outcome
12
2019
3302
0.290
Why?
Signal Transduction
8
2019
682
0.280
Why?
Antigens, Neoplasm
3
2019
45
0.280
Why?
Neoplasm Invasiveness
9
2016
190
0.280
Why?
Receptor, erbB-2
2
2018
65
0.280
Why?
Organ Specificity
2
2019
81
0.280
Why?
Bacteria
1
2007
48
0.270
Why?
Cell Line
4
2020
435
0.270
Why?
Systems Biology
1
2006
10
0.270
Why?
Leukocytes
2
2016
57
0.270
Why?
Male
22
2020
19143
0.270
Why?
Drug Resistance, Neoplasm
5
2018
104
0.260
Why?
Predictive Value of Tests
5
2015
873
0.260
Why?
Models, Biological
4
2019
392
0.260
Why?
Aged
16
2020
10294
0.260
Why?
Genetic Markers
2
2015
124
0.260
Why?
Genome, Human
6
2011
132
0.260
Why?
Antineoplastic Agents, Hormonal
4
2015
42
0.260
Why?
Gene Expression
7
2018
338
0.250
Why?
Models, Genetic
4
2011
94
0.250
Why?
Gene Regulatory Networks
2
2020
41
0.250
Why?
Thyroid Hormone Resistance Syndrome
1
2004
1
0.240
Why?
RNA, Small Interfering
9
2019
114
0.240
Why?
Coronavirus
1
2004
3
0.240
Why?
Disease Progression
6
2018
593
0.230
Why?
Cohort Studies
6
2018
1813
0.230
Why?
Antibodies, Monoclonal
2
2015
246
0.220
Why?
Ovarian Neoplasms
2
2017
96
0.220
Why?
Software
4
2008
123
0.210
Why?
Tumor Suppressor Proteins
3
2015
71
0.210
Why?
Neoplasm Proteins
3
2016
148
0.210
Why?
Estrogen Receptor Modulators
3
2012
25
0.210
Why?
Disease Models, Animal
2
2019
1022
0.210
Why?
Proteins
2
2015
144
0.200
Why?
Disease-Free Survival
6
2014
317
0.200
Why?
Bone Morphogenetic Protein 7
2
2020
18
0.200
Why?
Polymerase Chain Reaction
4
2016
198
0.200
Why?
Prostatic Neoplasms
2
2018
471
0.200
Why?
Immunohistochemistry
6
2016
538
0.200
Why?
Sulfides
3
2018
26
0.190
Why?
Caprylates
3
2018
27
0.190
Why?
Lymphatic Metastasis
3
2011
166
0.180
Why?
Survival Analysis
5
2018
482
0.180
Why?
DNA-Binding Proteins
2
2013
147
0.180
Why?
Co-Repressor Proteins
1
2020
3
0.180
Why?
Syndecan-1
1
2019
11
0.170
Why?
Neoplasm Metastasis
3
2016
220
0.170
Why?
Adenocarcinoma, Mucinous
1
2020
29
0.170
Why?
Plasma Cells
1
2019
11
0.170
Why?
Drug Screening Assays, Antitumor
1
2019
58
0.170
Why?
Promoter Regions, Genetic
5
2013
208
0.170
Why?
Immunologic Factors
1
2020
49
0.170
Why?
Leukocytes, Mononuclear
1
2019
56
0.170
Why?
DNA Primers
4
2008
91
0.170
Why?
Microarray Analysis
3
2010
19
0.170
Why?
DNA
5
2011
226
0.170
Why?
Phenotype
2
2016
632
0.170
Why?
Antigens, Nuclear
1
2019
7
0.170
Why?
Nuclear Matrix-Associated Proteins
1
2019
5
0.170
Why?
Magnetic Field Therapy
1
2019
17
0.170
Why?
DNA Breaks, Double-Stranded
1
2019
17
0.170
Why?
Gene Dosage
2
2009
35
0.170
Why?
Cystatin A
1
2019
8
0.170
Why?
Reproducibility of Results
5
2011
762
0.170
Why?
RNA Interference
4
2016
76
0.160
Why?
Interleukin-23 Subunit p19
1
2019
11
0.160
Why?
Calcium Channels, T-Type
1
2019
29
0.160
Why?
Myeloid Cells
1
2019
39
0.160
Why?
Mice, Nude
7
2013
291
0.160
Why?
Carcinoma, Bronchogenic
1
2018
7
0.160
Why?
RNA, Neoplasm
1
2018
20
0.160
Why?
DNA Repair
1
2019
64
0.160
Why?
Chemotherapy, Cancer, Regional Perfusion
1
2020
155
0.160
Why?
Organoids
1
2019
94
0.160
Why?
Combined Modality Therapy
1
2020
560
0.160
Why?
NAD
1
2018
27
0.160
Why?
Biopsy, Fine-Needle
1
2018
53
0.160
Why?
Membrane Glycoproteins
1
2018
101
0.150
Why?
SEER Program
1
2018
30
0.150
Why?
Esophageal Neoplasms
2
2008
35
0.150
Why?
DNA, Viral
3
2008
54
0.150
Why?
Neoplastic Stem Cells
3
2019
99
0.150
Why?
Hematologic Diseases
1
2017
23
0.140
Why?
Calcium
1
2019
307
0.140
Why?
Down-Regulation
6
2019
142
0.140
Why?
Sequence Analysis, DNA
4
2017
137
0.140
Why?
Retrospective Studies
3
2020
3502
0.140
Why?
Mitochondrial Diseases
1
2016
11
0.140
Why?
Recurrence
3
2019
263
0.140
Why?
Estradiol
4
2010
136
0.140
Why?
Nerve Sheath Neoplasms
1
2016
8
0.140
Why?
Neoplasms, Squamous Cell
1
2016
9
0.140
Why?
DNA Methylation
6
2015
140
0.140
Why?
Lymphocytes, Tumor-Infiltrating
1
2016
9
0.140
Why?
Chromosome Mapping
2
2008
193
0.140
Why?
Peptides
3
2016
120
0.140
Why?
Zebrafish
2
2006
23
0.140
Why?
Phosphorylation
3
2016
229
0.140
Why?
Sexual Maturation
1
2016
25
0.130
Why?
Immunomodulation
1
2016
32
0.130
Why?
Th1 Cells
1
2016
25
0.130
Why?
Multiprotein Complexes
1
2016
18
0.130
Why?
Radiosurgery
1
2019
356
0.130
Why?
Mammary Glands, Animal
1
2016
65
0.130
Why?
Proto-Oncogene Proteins c-akt
1
2016
70
0.130
Why?
Pancreatic Neoplasms
1
2017
134
0.130
Why?
Soybean Proteins
1
2016
74
0.130
Why?
Leukemia, Myeloid, Acute
1
2018
201
0.130
Why?
Receptors, Progesterone
3
2018
72
0.130
Why?
Colorectal Neoplasms
1
2017
215
0.120
Why?
Carboplatin
1
2015
48
0.120
Why?
Epithelial Cells
5
2016
141
0.120
Why?
Carrier Proteins
2
2016
136
0.120
Why?
DEAD Box Protein 20
1
2014
1
0.120
Why?
Paclitaxel
1
2015
67
0.120
Why?
Transplantation, Heterologous
5
2013
122
0.120
Why?
Apolipoproteins
1
2016
200
0.120
Why?
Urinary Bladder Neoplasms
1
2017
192
0.120
Why?
Severe Acute Respiratory Syndrome
2
2004
10
0.120
Why?
Lipoproteins, HDL
1
2016
251
0.120
Why?
Chemotherapy, Adjuvant
2
2012
190
0.120
Why?
Hematologic Neoplasms
1
2014
35
0.120
Why?
Iron Regulatory Protein 2
1
2013
2
0.120
Why?
Reverse Transcriptase Polymerase Chain Reaction
6
2011
263
0.120
Why?
Cell Movement
5
2014
169
0.120
Why?
Kidney Diseases
1
2016
249
0.110
Why?
SOXF Transcription Factors
1
2013
4
0.110
Why?
Skin Neoplasms
1
2016
214
0.110
Why?
NF-kappa B
2
2014
81
0.110
Why?
Estrogen Antagonists
2
2010
17
0.110
Why?
Epigenesis, Genetic
2
2015
104
0.110
Why?
Tumor Suppressor Protein p14ARF
1
2012
1
0.110
Why?
Cell Transformation, Neoplastic
2
2012
57
0.110
Why?
Proto-Oncogene Proteins c-mdm2
1
2012
8
0.110
Why?
Jumonji Domain-Containing Histone Demethylases
1
2012
1
0.100
Why?
Transforming Growth Factor beta2
1
2012
6
0.100
Why?
Cyclin-Dependent Kinase 2
1
2012
4
0.100
Why?
Cyclins
1
2012
6
0.100
Why?
Carcinoma, Squamous Cell
2
2019
154
0.100
Why?
Y-Box-Binding Protein 1
1
2011
1
0.100
Why?
Proliferating Cell Nuclear Antigen
1
2012
31
0.100
Why?
E2F1 Transcription Factor
1
2011
3
0.100
Why?
Protein Array Analysis
1
2011
15
0.100
Why?
Recombinases
1
2011
2
0.100
Why?
5' Untranslated Regions
1
2011
5
0.100
Why?
G-Quadruplexes
1
2011
8
0.100
Why?
DEAD-box RNA Helicases
1
2011
9
0.100
Why?
Gene Silencing
1
2011
48
0.100
Why?
Neoplasms, Hormone-Dependent
1
2011
9
0.100
Why?
Transfection
4
2018
191
0.100
Why?
Genes, Tumor Suppressor
2
2008
34
0.100
Why?
Mitochondria
3
2018
187
0.100
Why?
Sensitivity and Specificity
3
2008
582
0.090
Why?
Gene Knockdown Techniques
3
2019
77
0.090
Why?
Smad Proteins
1
2010
7
0.090
Why?
Aldehyde Dehydrogenase
1
2010
7
0.090
Why?
Receptors, Neurotensin
1
2010
1
0.090
Why?
Genetic Testing
1
2011
96
0.090
Why?
Neurotensin
1
2010
4
0.090
Why?
beta Catenin
1
2010
37
0.090
Why?
Cation Transport Proteins
1
2010
24
0.090
Why?
Models, Statistical
3
2006
173
0.090
Why?
Estrogens
1
2011
180
0.090
Why?
Estrogen Receptor beta
2
2007
13
0.090
Why?
Aged, 80 and over
5
2018
3988
0.090
Why?
Camptothecin
2
2017
51
0.090
Why?
rab GTP-Binding Proteins
1
2009
4
0.090
Why?
Genes, erbB-2
1
2009
6
0.090
Why?
Data Interpretation, Statistical
3
2008
109
0.080
Why?
Extracellular Signal-Regulated MAP Kinases
1
2009
35
0.080
Why?
Cyclin-Dependent Kinase Inhibitor p57
1
2009
1
0.080
Why?
Nerve Tissue Proteins
1
2010
120
0.080
Why?
Comparative Genomic Hybridization
1
2009
6
0.080
Why?
Carcinoma, Large Cell
1
2009
4
0.080
Why?
Antineoplastic Agents
1
2014
608
0.080
Why?
Chromosome Aberrations
1
2009
23
0.080
Why?
Cells, Cultured
3
2019
833
0.080
Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 5
1
2008
1
0.080
Why?
Nasopharyngeal Neoplasms
1
2008
5
0.080
Why?
Chromosomes, Human, Pair 13
1
2008
5
0.080
Why?
Thrombospondins
1
2008
6
0.080
Why?
Feasibility Studies
2
2019
293
0.080
Why?
Liver
2
2013
484
0.080
Why?
Carcinoma
1
2008
91
0.070
Why?
Genome, Viral
2
2004
10
0.070
Why?
Protein Binding
2
2019
201
0.070
Why?
Buchnera
1
2007
1
0.070
Why?
Genome, Bacterial
1
2007
6
0.070
Why?
Genes, cdc
2
2008
5
0.070
Why?
Bacteriological Techniques
1
2007
16
0.070
Why?
Arsenic
1
2006
3
0.070
Why?
Cell Cycle
4
2012
77
0.070
Why?
Databases, Genetic
2
2005
37
0.070
Why?
Escherichia coli
1
2007
87
0.070
Why?
Bacterial Infections
1
2007
51
0.070
Why?
Selective Estrogen Receptor Modulators
1
2006
36
0.070
Why?
Diagnosis, Computer-Assisted
1
2007
53
0.070
Why?
Liver Neoplasms, Experimental
1
2005
6
0.070
Why?
RNA, Messenger
3
2016
508
0.070
Why?
Apoptosis
3
2013
360
0.070
Why?
Pattern Recognition, Automated
1
2006
33
0.070
Why?
Precancerous Conditions
1
2005
27
0.060
Why?
Human Growth Hormone
1
2005
4
0.060
Why?
Binding Sites
4
2007
130
0.060
Why?
Xenograft Model Antitumor Assays
2
2019
115
0.060
Why?
Gene Expression Regulation, Fungal
1
2004
4
0.060
Why?
Schizosaccharomyces
1
2004
5
0.060
Why?
Estrogen Replacement Therapy
1
2006
199
0.060
Why?
Computer Simulation
1
2006
220
0.060
Why?
Up-Regulation
3
2012
189
0.060
Why?
Response Elements
1
2004
16
0.060
Why?
Genes, Neoplasm
1
2004
18
0.060
Why?
Cell Cycle Proteins
1
2004
55
0.060
Why?
Regulatory Sequences, Nucleic Acid
1
2004
24
0.060
Why?
Hyperthyroidism
1
2004
2
0.060
Why?
Thyroid Hormone Receptors beta
1
2004
2
0.060
Why?
Triiodothyronine
1
2004
7
0.060
Why?
Cerebellum
1
2004
26
0.060
Why?
Vero Cells
1
2004
3
0.060
Why?
Genes
1
2004
15
0.060
Why?
Mice, Inbred Strains
1
2004
48
0.060
Why?
Risk Factors
2
2016
3867
0.060
Why?
Base Composition
1
2004
10
0.060
Why?
Consensus Sequence
1
2004
10
0.060
Why?
Young Adult
3
2018
2635
0.060
Why?
Base Pair Mismatch
1
2004
6
0.060
Why?
Research Design
2
2005
313
0.060
Why?
Nucleic Acid Hybridization
1
2004
19
0.060
Why?
Molecular Sequence Data
3
2011
359
0.060
Why?
Base Sequence
3
2011
252
0.060
Why?
RNA, Viral
1
2004
48
0.060
Why?
Sequence Analysis, RNA
1
2004
28
0.060
Why?
Chromatin Immunoprecipitation
3
2011
21
0.060
Why?
Occupational Diseases
1
2004
81
0.060
Why?
Tissue Array Analysis
2
2016
34
0.060
Why?
Myocardium
1
2004
186
0.050
Why?
Intracellular Signaling Peptides and Proteins
2
2015
73
0.050
Why?
Neoplasm Transplantation
2
2013
73
0.050
Why?
Mice, Knockout
1
2004
443
0.050
Why?
Quality Control
1
2002
44
0.050
Why?
Cell Lineage
1
2002
71
0.050
Why?
Cyclin E
2
2012
5
0.050
Why?
Genes, Reporter
2
2011
40
0.050
Why?
Follow-Up Studies
2
2019
2265
0.050
Why?
DNA Damage
1
2002
98
0.050
Why?
Mice, Inbred C57BL
1
2004
767
0.050
Why?
Enzyme Inhibitors
1
2002
166
0.050
Why?
Adipose Tissue
1
2004
349
0.050
Why?
Loss of Heterozygosity
2
2012
20
0.050
Why?
Time Factors
1
2006
2147
0.050
Why?
Blotting, Western
2
2011
289
0.050
Why?
Peritoneum
1
2020
33
0.050
Why?
Immune System Phenomena
1
2020
5
0.040
Why?
Tomography, X-Ray Computed
2
2014
918
0.040
Why?
Cell Survival
2
2010
284
0.040
Why?
Calcium Channel Blockers
1
2019
48
0.040
Why?
Radiometry
1
2019
40
0.040
Why?
Tumor Cells, Cultured
2
2012
170
0.040
Why?
Lymph Nodes
1
2019
107
0.040
Why?
Acrylamides
1
2018
4
0.040
Why?
Hydroxamic Acids
2
2009
21
0.040
Why?
Nicotinamide Phosphoribosyltransferase
1
2018
13
0.040
Why?
Protein Kinases
1
2018
26
0.040
Why?
Tretinoin
1
2018
34
0.040
Why?
Cell Respiration
1
2018
22
0.040
Why?
Mitoxantrone
1
2018
19
0.040
Why?
Metaplasia
1
2018
19
0.040
Why?
Retreatment
1
2018
41
0.040
Why?
Cytarabine
1
2018
55
0.040
Why?
Pilot Projects
1
2019
545
0.040
Why?
Carcinoma, Ductal, Breast
1
2018
30
0.040
Why?
Fatty Acids
1
2018
98
0.040
Why?
Pathology, Molecular
1
2017
16
0.040
Why?
Bone Marrow
1
2018
70
0.040
Why?
Piperidines
1
2018
118
0.040
Why?
Lymphopenia
1
2017
11
0.040
Why?
Hypokalemia
1
2017
13
0.040
Why?
Leucovorin
1
2017
24
0.040
Why?
Neutropenia
1
2017
29
0.040
Why?
Hypoalbuminemia
1
2017
11
0.040
Why?
Sensation Disorders
1
2017
19
0.040
Why?
Thrombocytopenia
1
2017
30
0.040
Why?
Maximum Tolerated Dose
1
2017
62
0.040
Why?
Prospective Studies
2
2019
2278
0.040
Why?
Organoplatinum Compounds
1
2017
46
0.040
Why?
Oxygen Consumption
1
2018
154
0.040
Why?
Abdominal Pain
1
2017
44
0.040
Why?
Lipids
1
2018
232
0.040
Why?
Anemia
1
2017
58
0.040
Why?
Fluorouracil
1
2017
81
0.040
Why?
Cytokines
1
2018
255
0.040
Why?
B-Lymphocytes
1
2017
74
0.040
Why?
Biopsy
1
2018
259
0.040
Why?
Hyperglycemia
1
2017
84
0.030
Why?
Phytoestrogens
1
2016
23
0.030
Why?
Bayes Theorem
1
2016
80
0.030
Why?
Gene Knockout Techniques
1
2015
11
0.030
Why?
Structure-Activity Relationship
1
2016
80
0.030
Why?
Protein Transport
1
2015
74
0.030
Why?
DNA Modification Methylases
1
2015
11
0.030
Why?
DNA Repair Enzymes
1
2015
14
0.030
Why?
Sepsis
1
2017
158
0.030
Why?
Dose-Response Relationship, Radiation
1
2015
81
0.030
Why?
Species Specificity
2
2005
90
0.030
Why?
African Continental Ancestry Group
1
2016
363
0.030
Why?
Radiotherapy
1
2015
82
0.030
Why?
Salvage Therapy
1
2015
134
0.030
Why?
MAP Kinase Kinase Kinases
1
2014
4
0.030
Why?
I-kappa B Kinase
1
2014
8
0.030
Why?
Prostate
1
2015
68
0.030
Why?
Matrix Metalloproteinase 9
1
2014
30
0.030
Why?
Macaca fascicularis
1
2016
434
0.030
Why?
Leukemia
1
2014
40
0.030
Why?
Apoferritins
1
2013
4
0.030
Why?
Receptors, Transferrin
1
2013
10
0.030
Why?
Databases, Factual
1
2015
351
0.030
Why?
Clinical Trials as Topic
1
2016
301
0.030
Why?
Drug Administration Schedule
1
2014
276
0.030
Why?
Mammary Neoplasms, Experimental
1
2013
29
0.030
Why?
G2 Phase
2
2004
17
0.030
Why?
Cell Differentiation
1
2016
469
0.030
Why?
Diet
1
2016
391
0.030
Why?
Antigens, CD
1
2013
103
0.030
Why?
Positron-Emission Tomography
1
2014
163
0.030
Why?
Practice Guidelines as Topic
1
2016
407
0.030
Why?
Cyclin D1
1
2013
14
0.030
Why?
Cyclin D2
1
2013
7
0.030
Why?
Mice, SCID
1
2013
71
0.030
Why?
Internet
2
2004
195
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2012
22
0.030
Why?
European Continental Ancestry Group
1
2017
1166
0.030
Why?
Oncogene Proteins
1
2012
6
0.030
Why?
Cell Shape
1
2012
28
0.030
Why?
Cations, Monovalent
1
2011
1
0.030
Why?
DNA Footprinting
1
2011
1
0.030
Why?
GC Rich Sequence
1
2011
1
0.030
Why?
Circular Dichroism
1
2011
30
0.020
Why?
Protein Kinase Inhibitors
1
2012
85
0.020
Why?
Oligodeoxyribonucleotides
1
2011
17
0.020
Why?
Protein Processing, Post-Translational
1
2012
78
0.020
Why?
Trypsin Inhibitor, Kazal Pancreatic
1
2011
1
0.020
Why?
Far East
1
2011
3
0.020
Why?
Chromosomes, Human, Pair 19
1
2011
13
0.020
Why?
DNA Copy Number Variations
1
2011
13
0.020
Why?
Chromosomes, Human, Pair 16
1
2011
15
0.020
Why?
Prevalence
1
2014
981
0.020
Why?
Europe
1
2011
82
0.020
Why?
RNA
1
2011
92
0.020
Why?
Bone Morphogenetic Protein 2
1
2010
20
0.020
Why?
Retinal Dehydrogenase
1
2010
2
0.020
Why?
Mammary Glands, Human
1
2010
15
0.020
Why?
Antimicrobial Cationic Peptides
1
2010
14
0.020
Why?
Antibodies
1
2010
52
0.020
Why?
Neoplasms, Experimental
1
2010
29
0.020
Why?
Linear Models
1
2011
447
0.020
Why?
Cell Adhesion
1
2010
108
0.020
Why?
Cisplatin
1
2010
76
0.020
Why?
Proto-Oncogene Proteins c-bcl-2
1
2010
34
0.020
Why?
Recombinant Proteins
1
2010
247
0.020
Why?
Receptor Cross-Talk
1
2009
3
0.020
Why?
African Americans
1
2017
1425
0.020
Why?
Breast
1
2010
68
0.020
Why?
Expressed Sequence Tags
1
2009
2
0.020
Why?
Sex Factors
1
2011
661
0.020
Why?
Chromosomes, Human, Pair 3
1
2008
28
0.020
Why?
Multivariate Analysis
1
2010
683
0.020
Why?
Tumor Necrosis Factor-alpha
1
2009
210
0.020
Why?
Artifacts
1
2008
39
0.020
Why?
Chromosome Segregation
1
2008
3
0.020
Why?
Cell Line, Transformed
1
2008
18
0.020
Why?
Tumor Stem Cell Assay
1
2008
12
0.020
Why?
In Situ Hybridization, Fluorescence
1
2008
40
0.020
Why?
Microsatellite Repeats
1
2008
21
0.020
Why?
Epithelium
1
2008
30
0.020
Why?
Magnetic Resonance Imaging
1
2014
1328
0.020
Why?
Deoxycytidine
1
2008
68
0.020
Why?
Alleles
1
2008
248
0.020
Why?
E2F Transcription Factors
1
2007
1
0.020
Why?
Polymorphism, Single Nucleotide
1
2011
1062
0.020
Why?
Multigene Family
1
2007
51
0.020
Why?
Metabolic Networks and Pathways
1
2006
19
0.020
Why?
Premenopause
1
2006
44
0.020
Why?
Adaptation, Physiological
1
2006
55
0.020
Why?
HCT116 Cells
1
2006
11
0.020
Why?
Conserved Sequence
1
2005
20
0.020
Why?
Adolescent
1
2014
3537
0.020
Why?
Sequence Homology, Amino Acid
1
2005
70
0.020
Why?
Carcinogens
1
2005
35
0.020
Why?
RNA Probes
1
2005
4
0.020
Why?
DNA Probes
1
2005
19
0.020
Why?
Mucins
1
2005
18
0.020
Why?
Amino Acid Sequence
1
2005
285
0.020
Why?
Genome, Fungal
1
2004
1
0.020
Why?
ras-GRF1
1
2004
1
0.020
Why?
G1 Phase
1
2004
11
0.020
Why?
Fungal Proteins
1
2004
7
0.020
Why?
DNA, Complementary
1
2004
30
0.020
Why?
Normal Distribution
1
2004
12
0.020
Why?
Amino Acid Motifs
1
2004
24
0.020
Why?
S Phase
1
2004
15
0.020
Why?
Muscle Proteins
1
2005
59
0.020
Why?
Saccharomyces cerevisiae
1
2004
20
0.020
Why?
Oligonucleotides
1
2005
30
0.020
Why?
Temperature
1
2004
55
0.020
Why?
Software Design
1
2004
6
0.020
Why?
Genome
1
2004
38
0.020
Why?
Chromatin
1
2004
25
0.020
Why?
Singapore
1
2004
10
0.010
Why?
Cell Separation
1
2004
92
0.010
Why?
Laboratories
1
2004
15
0.010
Why?
Flow Cytometry
1
2004
185
0.010
Why?
DNA, Neoplasm
1
2004
55
0.010
Why?
Phylogeny
1
2004
56
0.010
Why?
Postmenopause
1
2006
430
0.010
Why?
Cell Nucleus
1
2004
108
0.010
Why?
Neoplasm Recurrence, Local
1
2006
367
0.010
Why?
Genotype
1
2004
733
0.010
Why?
Biomedical Research
1
2004
156
0.010
Why?
Aphidicolin
1
2002
1
0.010
Why?
Mitosis
1
2002
25
0.010
Why?
Biopsy, Needle
1
2002
93
0.010
Why?
Colonic Neoplasms
1
2002
71
0.010
Why?
Dose-Response Relationship, Drug
1
2002
632
0.010
Why?
Miller's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (479)
Explore
_
Co-Authors (68)
Explore
_
Similar People (50)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_